Laboratory Corporation of America Holdings (NYSE: LH) has cleared one of the conditions necessary for its $1.2 billion acquisition of Chiltern International Ltd. to close next month. The U.S. Federal Trade Commission has approved the deal, which is expected to close on or around Sept. 1. The Burlington-based company announced its acquisition of Chiltern in late July. The deal expands LabCorp's reach into the contract-research sector with Chiltern joining the company's Covance division when...
Chiltern is a contract research organization that provides clinical development services for diagnostics, pharmaceuticals and biotechnology industries.